ENGINEERED TO REDUCE SURGICAL SITE INFECTION. POSITIONED TO TRANSFORM PATIENT CARE.
OrthoFuzIon™ is a proprietary antimicrobial coating technology based on silver ionization, designed to prevent contamination associated with medical device implants.
How It WorksOrthoFuzIon™ deploys a platinum and silver coating engineered to enable controlled silver ion release.
Coated with Precision.
Upon implantation, the OrthoFuzIon™ Bone Screw System interacts with the body, causing the platinum to act as a catalyst that enables the release of silver ions. This triggers a galvanic reaction wherein the silver wears away gradually, creating a localized cloud of silver ions that surrounds the implanted device. This layer is designed to act as a deterrent to bacterial colonization and inhibit the growth of bacteria at the surgical site.
Activated through Galvanic Reaction.
The OrthoFuzIon™ Bone Screw System is one of the first antimicrobial medical devices specifically engineered for orthopedics, perfected over 15 years of development, testing, and animal trials. The foundation of this system is the proprietary AntiBacterIon® coating, a variable blend of platinum and silver plated directly onto the implantable device. This precise blend allows developers to tightly control the rate and overall duration of the silver's release once inside the body.
Device contamination during implantation causes postoperative complications, increasing patient morbidity and mortality. The localized cloud of silver ions effectively kills bacteria—including antibiotic-resistant species—while remaining non-toxic to humans. OrthoFuzIon® Bone Screws are indicated for open reduction and internal fixation (ORIF) fracture surgeries to inhibit microbial colonization and reduce surgical site infections (SSIs) in high-risk primary or revision surgeries. By preventing these infections, the technology addresses the CMS Bundled Payments for Care Improvement (BPCI) initiative, which holds healthcare providers financially responsible for the costs of post-procedure complications.
Designed to Inhibit Bacterial Growth.
Expert Insight“The incidence of resistant medical device-related infections is climbing. Certainly, the prevention of device failures and device-related infections would benefit patients as well as the entire healthcare system.”
— John D. Barr, MD
Professor of Radiology and Neurological surgery